Laboratorio Reig Jofre, S.A. (RJF.MC)
EUR 2.97
(2.06%)
EUR 2.97
(2.06%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 316.08 Million EUR | 16.57% |
| 2022 | 271.15 Million EUR | 14.78% |
| 2021 | 236.23 Million EUR | 2.67% |
| 2020 | 230.07 Million EUR | 14.92% |
| 2019 | 200.2 Million EUR | 10.94% |
| 2018 | 180.46 Million EUR | 7.43% |
| 2017 | 167.98 Million EUR | 4.25% |
| 2016 | 161.13 Million EUR | 2.69% |
| 2015 | 156.9 Million EUR | 371.42% |
| 2014 | 33.28 Million EUR | 6.1% |
| 2013 | 31.37 Million EUR | 4.83% |
| 2012 | 29.92 Million EUR | 1.5% |
| 2011 | 29.48 Million EUR | -24.09% |
| 2010 | 38.84 Million EUR | -71.15% |
| 2009 | 134.61 Million EUR | -16.4% |
| 2008 | 161.01 Million EUR | 5.3% |
| 2007 | 152.91 Million EUR | 68.48% |
| 2006 | 90.76 Million EUR | 93.19% |
| 2005 | 46.98 Million EUR | 102.34% |
| 2004 | 23.21 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 80.27 Million EUR | -6.99% |
| 2024 Q1 | 86.43 Million EUR | 9.68% |
| 2024 Q2 | 86.3 Million EUR | -0.15% |
| 2023 Q1 | 78.64 Million EUR | 3.62% |
| 2023 Q3 | 80.09 Million EUR | 1.97% |
| 2023 FY | 316.08 Million EUR | 16.57% |
| 2023 Q2 | 78.54 Million EUR | -0.12% |
| 2023 Q4 | 78.8 Million EUR | -1.6% |
| 2022 Q4 | 75.89 Million EUR | 21.04% |
| 2022 FY | 271.15 Million EUR | 14.78% |
| 2022 Q3 | 62.7 Million EUR | 0.0% |
| 2021 Q3 | 57.05 Million EUR | 5.66% |
| 2021 Q2 | 54 Million EUR | -13.06% |
| 2021 Q1 | 62.11 Million EUR | 4.09% |
| 2021 FY | 236.23 Million EUR | 2.67% |
| 2021 Q4 | 63.05 Million EUR | 10.51% |
| 2020 Q3 | 54.58 Million EUR | 1.51% |
| 2020 FY | 230.07 Million EUR | 14.92% |
| 2020 Q1 | 62.06 Million EUR | 16.86% |
| 2020 Q2 | 53.76 Million EUR | -13.36% |
| 2020 Q4 | 59.67 Million EUR | 9.33% |
| 2019 Q1 | 49.34 Million EUR | 4.67% |
| 2019 FY | 200.2 Million EUR | 10.94% |
| 2019 Q4 | 53.1 Million EUR | -2.23% |
| 2019 Q3 | 54.31 Million EUR | 25.02% |
| 2019 Q2 | 43.44 Million EUR | -11.95% |
| 2018 FY | 180.46 Million EUR | 7.43% |
| 2018 Q1 | 46.53 Million EUR | -3.9% |
| 2018 Q4 | 47.14 Million EUR | 9.17% |
| 2018 Q3 | 43.18 Million EUR | -0.98% |
| 2018 Q2 | 43.61 Million EUR | -6.28% |
| 2017 FY | 167.98 Million EUR | 4.25% |
| 2017 Q4 | 48.42 Million EUR | 36.62% |
| 2017 Q3 | 35.44 Million EUR | -12.2% |
| 2017 Q2 | 40.37 Million EUR | -7.7% |
| 2017 Q1 | 43.73 Million EUR | 4.53% |
| 2016 Q3 | 35.84 Million EUR | -12.63% |
| 2016 Q4 | 41.84 Million EUR | 16.73% |
| 2016 FY | 161.13 Million EUR | 2.69% |
| 2016 Q1 | 42.41 Million EUR | 4.07% |
| 2016 Q2 | 41.02 Million EUR | -3.26% |
| 2015 FY | 156.9 Million EUR | 371.42% |
| 2015 Q2 | 38.19 Million EUR | -11.17% |
| 2015 Q3 | 34.96 Million EUR | -8.46% |
| 2015 Q4 | 40.75 Million EUR | 16.57% |
| 2015 Q1 | 42.99 Million EUR | 403.95% |
| 2014 Q1 | 10.09 Million EUR | 66.38% |
| 2014 FY | 33.28 Million EUR | 6.1% |
| 2014 Q4 | 8.53 Million EUR | 21.61% |
| 2014 Q3 | 7.01 Million EUR | -8.17% |
| 2014 Q2 | 7.64 Million EUR | -24.33% |
| 2013 Q3 | 7.14 Million EUR | -3.71% |
| 2013 Q4 | 6.06 Million EUR | -15.05% |
| 2013 FY | 31.37 Million EUR | 4.83% |
| 2013 Q1 | 10.74 Million EUR | -17.8% |
| 2013 Q2 | 7.41 Million EUR | -30.94% |
| 2012 Q1 | 9.46 Million EUR | -10.44% |
| 2012 Q2 | 7.39 Million EUR | -21.9% |
| 2012 Q3 | 6.73 Million EUR | -8.94% |
| 2012 Q4 | 13.06 Million EUR | 94.1% |
| 2012 FY | 29.92 Million EUR | 1.5% |
| 2011 Q1 | 11.76 Million EUR | 0.0% |
| 2011 Q4 | 10.57 Million EUR | 0.0% |
| 2011 FY | 29.48 Million EUR | -24.09% |
| 2011 Q2 | 7.14 Million EUR | -39.25% |
| 2010 Q1 | 14.43 Million EUR | 0.0% |
| 2010 Q2 | 10.13 Million EUR | -29.77% |
| 2010 FY | 38.84 Million EUR | -71.15% |
| 2009 Q1 | 41.34 Million EUR | 0.0% |
| 2009 FY | 134.61 Million EUR | -16.4% |
| 2008 FY | 161.01 Million EUR | 5.3% |
| 2007 FY | 152.91 Million EUR | 68.48% |
| 2006 FY | 90.76 Million EUR | 93.19% |
| 2005 FY | 46.98 Million EUR | 102.34% |
| 2004 FY | 23.21 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Almirall, S.A. | 894.51 Million EUR | 64.664% |
| Faes Farma, S.A. | 451.16 Million EUR | 29.94% |